Zulu Room

Christie Conference Centre

Level 4, 100 Walker Street, North Sydney

2:00 pm 27 November 2013

2016 Annual General Meeting

2.00pm, 30 NOVEMBER 2016

The Boardroom

Northside Conference Centre

Corner of Oxley Street and Pole Lane

Crows Nest NSW 2065

1

For

per

sona

l use

onl

y

2

Important Information

This presentation has been prepared by Intec Ltd (Intec) based on information available to it as at the date of this presentation. The information is provided in summary form and does not contain all information necessary to make an investment decision. Hence, no representation is made as to the accuracy, completeness or reliability of the information. In addition, neither Intec nor any of its subsidiaries, directors, employees, shareholders nor any other person shall have liability whatsoever to any person for any loss, including without limitation from any fault or negligence arising from this presentation or any information supplied in connection with it.

This presentation may contain forward-looking statements and projections. These reflect Intec’s current expectations, based on what it believes to be reasonable assumptions. Intec gives no warranty or representation as to its future financial performance or any future matter. Except as required by law or ASX listing rules, Intec is not obliged to update this presentation after its release, even if matters change materially. This presentation does not constitute financial advice. Further, this presentation is not and should not be construed as an offer to sell or a solicitation of an offer to buy Intec securities and may not be relied upon in connection with any purchase of Intec securities.

For

per

sona

l use

onl

y

AGENDA Chairman's Introduction

Managing Director’s Presentation

Meeting Resolutions

3

For

per

sona

l use

onl

y

• Shares on issue: 299.8 million

• Market Capitalisation: $4.5 million at 1.3 cts

• Top 20 Shareholders: 54%

• Management & Board: 15%*

• Cash at 30 September 2016: $0.4 million

• 50% interest in Science Developments Pty Ltd (SciDev)

• Option to acquire the remaining 50% of SciDev – expiry 28/2/17

• Other: Intec Process licensing agreement with Intec International Projects – 5% royalty on revenue

Ownership of Zeehan Slag dump, approximately 430,000 tonnes @ 14% zinc

2.5% net smelter royalty over certain tenements in Hellyer region, Tasmania

* Including SciDev management

4

For

per

sona

l use

onl

y

SciDev established in 2001 to commercialise technologies developed in the area of wastewater treatment chemicals.

Specific focus is the manufacture of cationic coagulants and the supply of specialty flocculants.

Product range sold under 4 (registered) brands with DairyFlox® and MaxiFlox® being established brands while OptiFlox® and BioFlox® being recent product introductions.

5

For

per

sona

l use

onl

y

The investment story

• SciDev is a profitable business serving a blue chip customer base in the dairy, food, quarrying, gold, coal seam gas and waste treatment industries.

• Near term revenue & profit growth will come from the rollout of OptiFlox® Systems (patent pending) in the Australian coal and dairy industries.

• First OptiFlox® System successfully completed 6-month trial at Wilpinjong mine (owned by Peabody Energy, the world’s largest non-government coal mining company).

• Enhanced system to be permanently installed at Wilpinjong next week and two year contract covering on-going supply of system and chemicals being finalised.

• OptiFlox® System developed to provide productivity and cost benefits to the customer and increase chemical sales for SciDev.

• Business model: Monthly licence fee for use of system but customers must use SciDev coagulant.

• Revenue per coal site estimated at $200,000 to $450,000 (chemical sales and licence fees) dependent upon plant throughput.

6

For

per

sona

l use

onl

y

Near term growth opportunities

• Rollout of OptiFlox® System in Australian Coal Industry

Market Size: 68 coal washing plants in Australia

Target market penetration: 20 installed OptiFlox® Systems over next 3 years

Revenue opportunity: $200,000 to $450,000 per site dependent on plant throughput

Currently undertaking testwork at three other Peabody Energy sites and two other sites operated by major coal industry participants.

• Commercial trial in Australian dairy industry during 2017; current discussions with two large industry participants.

• International licensing arrangements; coal related – USA, South Africa & Canada

• Expansion into other industries: sewage, etc. 7

For

per

sona

l use

onl

y

0

20

40

60

80

100

22

/09

/20

16

06

:00

:01

22

/09

/20

16

06

:45

:50

22

/09

/20

16

07

:32

:38

22

/09

/20

16

08

:18

:27

22

/09

/20

16

09

:05

:14

22

/09

/20

16

09

:53

:59

22

/09

/20

16

10

:41

:45

22

/09

/20

16

11

:29

:31

22

/09

/20

16

12

:15

:21

22

/09

/20

16

13

:01

:12

22

/09

/20

16

13

:47

:02

22

/09

/20

16

14

:33

:50

22

/09

/20

16

15

:19

:41

22

/09

/20

16

16

:05

:31

22

/09

/20

16

16

:51

:21

22

/09

/20

16

17

:37

:11

22

/09

/20

16

18

:23

:01

22

/09

/20

16

19

:08

:51

22

/09

/20

16

19

:54

:40

22

/09

/20

16

20

:40

:30

22

/09

/20

16

21

:26

:19

22

/09

/20

16

22

:12

:08

22

/09

/20

16

23

:06

:44

22

/09

/20

16

23

:52

:34

23

/09

/20

16

00

:39

:22

23

/09

/20

16

01

:26

:09

23

/09

/20

16

02

:16

:51

23

/09

/20

16

03

:02

:40

23

/09

/20

16

03

:48

:29

23

/09

/20

16

04

:35

:17

23

/09

/20

16

05

:21

:06

23

/09

/20

16

06

:06

:54

23

/09

/20

16

06

:52

:43

23

/09

/20

16

07

:41

:27

23

/09

/20

16

08

:27

:16

ALG

Val

ue

& C

he

mic

al D

ose

Rat

e

OptiFlox® System - Wilpinjong Site Data22 & 23 September 2016

ALG Set Point

ALG Actuals

OptiFlox® Chemical Dosing

SciDev coagulant is automatically dosed [at the appropriate rate] when the actual ALG climbs above the ALG set point. Coagulant dosing is maintained until the ALG returns to below the desired set point.

Illustrates times when no or minimal coagulant dosing is required.

For

per

sona

l use

onl

y

OptiFlox® System

Mark 1 System

9

Initial Mark-1 System employed at Wilpinjong for commercial trial

For

per

sona

l use

onl

y

Mark 2 OptiFlox® System

10

Exclusive OptiFlox® System manufacturing/customer arrangement agreed with Burkert Fluid Control Systems (German multinational).

For

per

sona

l use

onl

y

11Private & Confidential - Not for distribution

OptiFlox® Mark-2 System designed based on results of Wilpinjong six-month trial- smaller foot print and enhanced operating and reporting capabilities- first system will be installed Wilpinjong next week

For

per

sona

l use

onl

y

12

Country <5 mtpa 5-10 mtpa 10-15 mtpa >15 mtpa Total

Australia 30 26 11 1 68

Canada 10 4 - - 14

China 1,390 500 100 10 2,000+

Poland 16 19 4 - 39

India 53 5 2 60

Russia - - - - 56

South Africa 30 30 - - 60

Turkey 40 10 - - 50

USA 144 75 30 20 269

Market Opportunity in Coal Washing Plants *

* Source: 2016 International Coal Preparation Congress. Not all countries listed.

For

per

sona

l use

onl

y

Other Activities

Zeehan Slag Dump ~ approximately 430,000 tonnes at 14% Zn

Granted mining lease and development authority

Value realisation likely to commence in 2017

13

For

per

sona

l use

onl

y

Intec 2016 Annual General Meeting

www.intec.com.auThe results of this AGMwill shortly be available on the Intec web site.

14

For

per

sona

l use

onl

y